Characterization of a major form of human isatin reductase and the reduced metabolite.
about
Tissue distribution, ontogeny, and chemical induction of aldo-keto reductases in miceHuman carbonyl reduction pathways and a strategy for their study in vitro.The Ralstonia solanacearum pathogenicity regulator HrpB induces 3-hydroxy-oxindole synthesisAldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health.Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily.Carbonyl reduction pathways in drug metabolism.The modulation of carbonyl reductase 1 by polyphenols.The role of carbonyl reductase 1 in drug discovery and development.Synthesis characterization and biological activity study of new schiff and mannich bases and some metal complexes derived from isatin and dithiooxamide.Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.Biological targets for isatin and its analogues: Implications for therapy.Diacetyl/l-Xylulose Reductase Mediates Chemical Redox Cycling in Lung Epithelial Cells.In vivo effects of isatin on rat platelet eicosanoids.Synthesis of 8-hydroxy-2-iminochromene derivatives as selective and potent inhibitors of human carbonyl reductase 1.
P2860
Q28677003-4BA633BB-D2C9-4921-BA0C-7A0210261E72Q35828036-47D1FB8F-B235-49FF-8095-1F87A0A2A61FQ36023878-D4A09DAC-FEEE-4AE4-9266-B078B2B5F8DFQ36370381-B7648BE8-7DA9-49FA-9B9B-647A3FA188CEQ36761677-E270E64C-DBAC-4D72-B1A0-FD26F513EE46Q38156452-31742B84-B24A-4B3B-950C-E707314E5567Q38594695-46E61D8D-7D8A-4A11-8E65-9B3D09D0AA07Q38656979-A18BEF85-FBE8-4E25-A7CB-86F37ECB0EFBQ39467751-65A27C8F-0AA2-438D-A4F3-761B9C224087Q42947243-4B16FD87-D084-47A6-9176-18C036F6B287Q43078223-D099F322-9EED-429C-9359-13D2ADFA01ACQ46354112-625D0DC8-C037-4ABE-8576-E992BEC1C6E8Q46374411-88F0414D-6216-4D9D-B370-54227A52B3C6Q53470171-E2FE9A0B-9756-49DB-9F34-74DCB2EAE38B
P2860
Characterization of a major form of human isatin reductase and the reduced metabolite.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Characterization of a major form of human isatin reductase and the reduced metabolite.
@en
Characterization of a major form of human isatin reductase and the reduced metabolite.
@nl
type
label
Characterization of a major form of human isatin reductase and the reduced metabolite.
@en
Characterization of a major form of human isatin reductase and the reduced metabolite.
@nl
prefLabel
Characterization of a major form of human isatin reductase and the reduced metabolite.
@en
Characterization of a major form of human isatin reductase and the reduced metabolite.
@nl
P2093
P2860
P1433
P1476
Characterization of a major form of human isatin reductase and the reduced metabolite.
@en
P2093
P2860
P304
P356
10.1046/J.0014-2956.2001.02510.X
P407
P577
2001-11-01T00:00:00Z